Medpage Today -- LINKOPING, Sweden, Oct. 8 -- Immunotherapy against a major autoantigen in type 1 diabetes may preserve beta-cell function early after disease onset but not reverse the process, researchers said.
Medpage Today -- LINKOPING, Sweden, Oct. 8 -- Immunotherapy against a major autoantigen in type 1 diabetes may preserve beta-cell function early after disease onset but not reverse the process, researchers said.
